Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction-Reference-Cited by-同舟云学术

Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction

Published:2001-04 Issue:4 Volume:31 Page:349-355
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Mitolo-Chieppa D.,Mansi G.,Nacci C.,De Salvia M. A.,Montagnani M.,Potenza M. A.,Rinaldi R.,Lerro G.,Siro-Brigiani G.,Mitolo C. I.,Rinaldi M.,Altomare D. F.,Memeo V.

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2362.2001.00810.x/fullpdf

Reference23 articles.

1. Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors;Maggi;Gastroenterology,1992

2. Hyoscine-resistant peristalsis in guinea-pig ileum;Tonini;Eur J Pharmacol,1981

3. Evidence for the involvement of substance P in the atropine-resistant peristalsis of the guinea-pig ileum;Barthò;Neurosci Letts,1982

4. Peptides and the human colon: an in vitro pharmacological study;Couture;Can J Physiol Pharmacol,1981

5. NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype;Giuliani;Eur J Pharmacol,1991

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreases in mucosally‐evoked tachykinin signaling pathways can explain age‐related reductions in murine colonic motility patterns;Neurogastroenterology & Motility;2024-08-18

2. Lubeluzole: from anti-ischemic drug to preclinical antidiarrheal studies;Pharmacological Reports;2020-10-19

3. Gender-Related Differences of Tachykinin NK2Receptor Expression and Activity in Human Colonic Smooth Muscle;Journal of Pharmacology and Experimental Therapeutics;2020-08-06

4. Functional Constipation: Individualising Assessment and Treatment;Drugs;2020-05-25

5. THE PLACE OF TACHYKININ NK2 RECEPTOR ANTAGONISTS IN THE TREATMENT DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME;J PHYSIOL PHARMACOL;2019